MCT Oil

Does MCT oil help with weight loss and energy?

MCT oil likely gives a small boost to weight and fat loss and raises ketones, but it does not improve athletic endurance.

MCT oil is a concentrated source of medium-chain fatty acids derived from coconut or palm kernel oil. Unlike most dietary fats, MCTs skip standard digestion and travel directly to the liver, where they are rapidly converted into ketones — a clean-burning fuel the brain can use when glucose availability is low1. This makes MCT oil popular among people following low-carbohydrate diets and has attracted genuine research interest for cognitive support, fat metabolism, and gut health. A modest dose — one or two tablespoons per day — is practical and well-studied2,3.

What you can do

  • Start with 1 teaspoon and build to 1–2 tablespoons a day over 1–2 weeks to avoid cramping and loose stools.
  • Use it in place of other fats rather than on top; the weight trials swapped MCTs for long-chain fats such as olive oil3.
  • Add it to coffee, smoothies or other cold or low-heat foods; it is not suited to high-heat cooking.

Be careful if

  • Digestive upset (cramping, loose stools) is the main side effect; it is dose-dependent and reversible, and about 30 g a day was well tolerated.
  • Do not use it to treat a gut infection: the C. difficile results are lab-only, with no clinical trials4.
How it works What it does in your body, in plain words 3 min

Most dietary fats are long-chain triglycerides (LCTs) — found in olive oil, butter, and nuts — that require bile emulsification and enter the lymphatic system before reaching the bloodstream. Medium-chain triglycerides (primarily C8 caprylic acid and C10 capric acid) bypass this route entirely. They absorb directly through the intestinal wall into the portal vein, heading straight to the liver for rapid oxidation or conversion into ketone bodies: beta-hydroxybutyrate and acetoacetate.

Ketones are an alternative brain fuel that cross the blood-brain barrier readily. The brain normally runs on glucose, but in states of low carbohydrate intake, metabolic aging, or impaired brain glucose metabolism, ketones can partially compensate. This metabolic versatility is the central mechanism behind most of MCT oil's studied benefits1.

Brain Health and Cognitive Support

Brain glucose metabolism tends to decline with age, and more markedly in people developing cognitive impairment. A PET imaging study found that MCT supplementation roughly doubled brain ketone uptake in Alzheimer's patients, with the degree of compensation directly proportional to the plasma ketone level achieved — meaning higher doses produced greater brain fuel support1. For brain ketone benefits, a minimum of about 30 g/day appears necessary, and the effect is amplified on lower-carbohydrate eating patterns that don't blunt ketone production.

The research is most compelling for people with existing glucose metabolism impairment, though healthy people also produce measurable ketones from MCT supplementation.

Weight and Body Composition

MCT oil modestly supports fat loss through two mechanisms: slightly higher thermogenesis compared to LCTs (they oxidize more readily than they store), and a meaningful reduction in subsequent food intake.

A 2020 systematic review of 17 studies found a statistically significant moderate decrease in calorie consumption after MCT versus LCT intake under laboratory conditions6. Interestingly, subjective hunger ratings did not change — people ate less without feeling less hungry, suggesting a physiological satiety signal distinct from perceived hunger.

A meta-analysis of 13 randomized controlled trials found that replacing LCTs with MCTs produced modest but consistent reductions in body weight, waist circumference, and visceral fat, without adverse effects on blood lipid profiles2. A 16-week RCT comparing MCT oil to olive oil within the same calorie-restricted diet found MCT oil produced 1.67 kg more weight loss, with lower trunk fat and intraabdominal adipose tissue3.

These effects are real but modest. MCT oil is not a weight-loss shortcut — it is best understood as a metabolic upgrade to an already-sound diet.

Antimicrobial and Gut Effects

The fatty acids in MCT oil — especially caprylic acid (C8) and lauric acid (C12) — disrupt the cell membranes of certain pathogens. Laboratory studies show inhibition of Clostridium difficile growth, with lauric acid being the most potent and capric and caprylic acids also effective4. Caprylic acid has a long history of use for Candida overgrowth and gut dysbiosis, though large clinical trials are lacking. These antimicrobial properties may partially explain why MCT oil is sometimes used in gut-healing protocols.

Athletic Performance

Despite plausible mechanisms — faster fat oxidation, ketone availability — the evidence for MCT oil improving endurance performance is largely null. A 2022 systematic review of 18 studies found that most reported no effect on respiratory exchange ratio, fat oxidation, carbohydrate utilization, lactate, or exercise time-to-exhaustion5. Ketone levels consistently rise during exercise with MCT consumption, but this does not translate to meaningful glycogen sparing or performance gains in well-nourished athletes.

Practical Use

  • Starting dose: Begin with 1 teaspoon to avoid digestive upset (cramping, loose stools); increase gradually to 1-2 tablespoons over 1-2 weeks
  • Coffee and smoothies: MCT oil has virtually no flavor and blends into any liquid
  • Cooking: Not suitable for high-heat cooking; better used cold or at low temperatures
  • C8 vs. blends: Pure caprylic acid (C8) produces more ketones per gram; lauric-acid-heavy coconut oil produces fewer ketones but has broader antimicrobial activity
  • Timing: Some people use it in the morning to extend cognitive alertness; others use it before meals to reduce appetite

See our coconut oil page for related discussion of lauric acid and MCTs in whole-food form.

The evidence The studies, what they found, and how much to trust them 4 min · 7 sources

Brain energy metabolism (PMID 29914035)

Croteau et al. (2018) used PET imaging to directly measure brain uptake of both ketones and glucose in 20 Alzheimer's patients and 20 age-matched controls before and after supplementation with two types of MCT-based ketogenic supplement. Brain ketone consumption approximately doubled with both supplements; brain glucose uptake remained unchanged (impaired). The increase in ketone utilization was proportional to plasma ketone concentrations achieved. The study was well-controlled with repeated measures and objective imaging endpoints, making it one of the strongest mechanistic demonstrations that MCT-derived ketones can partially compensate for brain glucose deficits in Alzheimer's disease.

A 2020 systematic review and meta-analysis (literature searched to March 2019) pooled 12 studies with 422 participants who had mild cognitive impairment or Alzheimer's disease. Compared with placebo, MCTs raised blood beta-hydroxybutyrate by about 0.36 mmol/L (95% CI 0.29 to 0.42), showed only a trend toward improvement on the ADAS-Cog scale, and modestly improved a combined cognitive measure (standardized mean difference −0.29, 95% CI −0.55 to −0.03). Heterogeneity was low (I² = 0%), but the authors noted a risk of bias in the existing studies and called for further trials7.

Weight and body composition (PMIDs 25636220, 18326600)

Mumme and Stonehouse's 2015 meta-analysis (13 RCTs, n=749) compared MCTs (C8/C10 specifically) to LCTs on weight and composition outcomes:

  • Body weight: -0.51 kg (95% CI -0.80 to -0.23, p<0.001)
  • Waist circumference: -1.46 cm (95% CI -2.04 to -0.87, p<0.001)
  • Hip circumference: -0.79 cm (95% CI -1.27 to -0.30, p=0.002)
  • Visceral fat, subcutaneous fat, and total body fat all significantly reduced
  • No significant difference in LDL, HDL, or total cholesterol2

The RCT by St-Onge and Bosarge (2008) enrolled 49 overweight adults (BMI ~30) in a 16-week parallel-arm trial comparing 18-24 g/day MCT oil vs. olive oil within an identical calorie-restricted diet. Of 31 completers, the MCT group showed significantly lower endpoint body weight (-1.67 kg, p=0.013), trunk fat mass, total fat mass, and intraabdominal adipose tissue compared to olive oil. The study design — identical caloric restriction across groups — isolates the metabolic effect of MCT vs. LCT rather than any overall diet change3.

Satiety and food intake (PMID 32212947)

Maher and Clegg (2020) reviewed 17 studies (291 participants) and conducted a meta-analysis on 11 that measured energy intake outcomes. They found a statistically significant moderate decrease in ad libitum energy intake with MCT versus LCT (mean effect size -0.444, 95% CI -0.808 to -0.080, p=0.017). Notably, this reduction in consumption was not accompanied by changes in subjective appetite ratings or circulating hunger hormones (PYY, GLP-1, ghrelin). The authors speculate that the mechanism may involve portal vein signaling rather than systemic hormone changes, but this remains to be confirmed6.

Athletic performance (PMID 36096496)

Chapman-Lopez and Koh (2022) reviewed 18 studies examining MCT oil and endurance performance. The majority found no statistically significant effect on any performance metric: time to exhaustion, power output, respiratory exchange ratio, substrate oxidation, blood lactate, or glucose. Ketone levels reliably increased in studies providing MCTs before or during exercise — but this ketogenic response did not appear to spare glycogen or reduce carbohydrate dependence during moderate-to-high intensity exercise. The authors conclude that MCT oil "showed very little to no ergogenic effects" in healthy populations5.

Antimicrobial effects (PMID 24328700)

Shilling et al. (2013) tested the inhibitory activity of virgin coconut oil and its component fatty acids against C. difficile in culture. Lauric acid (C12) was the most potent inhibitor; capric acid (C10) and caprylic acid (C8) showed dose-dependent inhibition at concentrations of 0.15-1.2% lipolyzed coconut oil. Whole (non-hydrolyzed) coconut oil did not inhibit C. difficile, suggesting the effect requires enzymatic liberation of free fatty acids — as occurs during digestion4. These findings are in-vitro only; no clinical trials have tested MCT oil directly for C. difficile infection. The antimicrobial data is best interpreted as mechanistic support for in-vivo gut effects rather than clinical evidence.

Overall evidence strength

The strongest evidence supports brain energy support (mechanistic + RCT data in MCI/AD) and modest weight/composition benefits (multiple RCTs, consistent meta-analyses). The satiety evidence is moderately strong. The antimicrobial and gut health evidence is mechanistically plausible but clinically untested. The athletic performance evidence is a notable null — the mechanism exists but the real-world effect does not appear to materialize in most study populations. MCT oil is well-tolerated up to approximately 30 g/day; gastrointestinal symptoms are the primary adverse effect and are dose-dependent and reversible.

  1. Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano CA, Richard MA, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte EE, Bocti C, Fulop T, Cunnane SC. Journal of Alzheimer's Disease, 2018. PubMed 29914035
  2. Effects of Medium-Chain Triglycerides on Weight Loss and Body Composition: A Meta-Analysis of Randomized Controlled Trials. Mumme K, Stonehouse W. Journal of the Academy of Nutrition and Dietetics, 2015. PubMed 25636220
  3. Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. St-Onge MP, Bosarge A. American Journal of Clinical Nutrition, 2008. PubMed 18326600
  4. Antimicrobial effects of virgin coconut oil and its medium-chain fatty acids on Clostridium difficile. Shilling M, Matt L, Rubin E, Visitacion MP, Haller NA, Grey SF, Woolverton CJ. Journal of Medicinal Food, 2013. PubMed 24328700
  5. The Effects of Medium-Chain Triglyceride Oil Supplementation on Endurance Performance and Substrate Utilization in Healthy Populations: A Systematic Review. Chapman-Lopez TJ, Koh Y. Journal of Obesity and Metabolic Syndrome, 2022. PubMed 36096496
  6. A systematic review and meta-analysis of medium-chain triglycerides effects on acute satiety and food intake. Maher T, Clegg ME. Critical Reviews in Food Science and Nutrition, 2020. PubMed 32212947
  7. Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies. Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D. Ageing Research Reviews, 2020. PubMed 31870908

Every change to this page is tracked in version control. View edit history. If you have conflicting research, we want to hear about it.

Spotted something wrong or out of date? Suggest a change.

Weekly research digest

New topics and updated research, once a week when there's something new. How it works